Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,149.15 +17.73 (+1.57%)

Official Closing Price Updated: 7:00 PM EDT, Jun 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Why Eli Lilly Stock Climbed to a New All-Time High Today ↗

June 08, 2026

The pharma giant is well-positioned to lead the $200 billion global obesity treatment market.

Via The Motley Fool

Prediction: The Trump Bull Market Will Soon End -- But These 2 Stocks Will Keep Winning Anyway ↗

June 08, 2026

These stocks may deliver gains during any market environment.

Via The Motley Fool

Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy? ↗

June 08, 2026

Infectious disease could fuel Eli Lilly's next growth phase.

Via The Motley Fool

Stock Market Today, June 8: Marvell, Intel, and Micron Lead Tech Stock Rebound ↗

June 08, 2026

Marvell’s leap into the S&P 500 caps a sharp AI-chip rebound that helped steady U.S. stocks, today, June 8, 2026.

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

Why Eli Lilly (LLY) Stock Is Up Today

June 08, 2026

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 2.1% in the afternoon session after the company reported positive Phase 3 ...

Via StockStory

Why Eli Lilly, In A Buy Zone, Is Still The 'Clear Winner' Of The 'Weight Loss Olympics' ↗

June 08, 2026

Eli Lilly emerged as the "clear winner" from the ADA meeting last weekend in New Orleans, an analyst said following the event.

Via Investor's Business Daily

A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk. ↗

June 08, 2026

Zealand Pharma's stock is cratering today after disappointing results from a late-stage trial of its GLP-1 dual-receptor agonist drug.

Via The Motley Fool

Is the Vanguard Growth ETF (VUG) the Right Fit for Your Portfolio? ↗

June 08, 2026

How does an average annual gain of 18% over the past decade sound?

Via The Motley Fool

Topics ETFs

Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages ↗

June 08, 2026

Eli Lilly reports Foundayo delivered significant weight loss across menopausal stages, with up to 14.4% reductions at 72 weeks.

Via Benzinga

Want to Avoid SpaceX, Anthropic, and OpenAI? Buy This Low-Cost Vanguard ETF. ↗

June 08, 2026

Getting exposure to high-profile IPOs is easier than ever through low-cost index funds and ETFs.

Via The Motley Fool

Topics Artificial Intelligence ETFs Initial Public Offering

Eli Lilly Could Become The World's Top AI Firm? Jordi Visser Has Reasons To Believe Mounjaro Maker Could Become The Largest Company Globally ↗

June 08, 2026

Investor Jordi Visser says Eli Lilly could become the world's largest company and AI leader within five years due to its AI advantage.

Via Benzinga

Topics Artificial Intelligence

Q1 Earnings Review: Branded Pharmaceuticals Stocks Led by Eli Lilly (NYSE:LLY)

June 07, 2026

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Want Nothing to Do With SpaceX? Buy This Ultra-Low-Cost Dividend Growth ETF in June. ↗

June 07, 2026

The Vanguard Dividend Appreciation ETF is the perfect fit for investors looking to build a portfolio around high-quality companies that pay growing dividends.

Via The Motley Fool

Topics ETFs Stocks

80% of Wegovy Pill Users Never Took a Weight Loss Drug Before. Does This Number Change the Entire Novo Nordisk Bear Case? ↗

June 07, 2026

Novo Nordisk could maintain this latest early-mover advantage longer than you think.

Via The Motley Fool

Micron Makes the $1 Trillion Club a Little More Crowded ↗

June 06, 2026

Micron has had a turnaround for the ages, going from a free cash flow negative company to a $1 trillion valuation in a little over a year.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing ↗

June 06, 2026

Eli Lilly just announced a trio of acquisitions that will allow it to build a new business focused on infectious diseases.

Via The Motley Fool

Topics Intellectual Property

Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems ↗

June 06, 2026

Investors are clearly worried about the safety of Pfizer's dividend, which is reasonable.

Via The Motley Fool

Topics Intellectual Property

Prediction: Eli Lilly Will Reach $1,200 in 2026 ↗

June 06, 2026

International growth could help push Lilly even higher.

Via The Motley Fool

Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now? ↗

June 06, 2026

Investors appear to have left Novo Nordisk behind as they focus on Eli Lilly; that could be a mistake.

Via The Motley Fool

Topics Intellectual Property

Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support ↗

June 06, 2026

The stock market appears to be rotating into health care.

Via Investor's Business Daily

Here's How Much $1000 Invested In Eli Lilly 5 Years Ago Would Be Worth Today ↗

June 05, 2026

Via Benzinga

Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors. ↗

June 05, 2026

One fund backs medical breakthroughs and charity, while the other favors industry giants and steady income. Compare their strategies and portfolio makeup.

Via The Motley Fool

Topics ETFs

Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech ↗

June 05, 2026

Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs take different paths to long-term returns.

Via The Motley Fool

Topics ETFs

CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors ↗

June 05, 2026

It's another step in Eli Lilly's quest to cement its lead in the chronic weight management market.

Via The Motley Fool

Why WeightWatchers (WW) Stock Is Trading Up Today

June 04, 2026

What Happened? Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 6.3% in the afternoon session after the company announced its Weight Wat...

Via StockStory

Topics Artificial Intelligence Bonds Credit Cards

AbCellera Biologics Bets on Hot Flash Antibody as Pipeline Pivot Gains Steam ↗

June 04, 2026

AbCellera Biologics (NASDAQ:ABCL) is emphasizing its transition from a partner-based antibody discovery business to a proprietary drug development company, Chief Financial Officer Andrew Booth said...

Via MarketBeat

Stock Market Today, June 4: Broadcom Drags on Nasdaq at Midday ↗

June 04, 2026

Broadcom’s weak AI-chip guidance rattled semiconductors and raised questions about tech valuations today, June 4, 2026.

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

Stay informed with the top movers within the S&P500 index on Thursday. ↗

June 04, 2026

Via Chartmill

Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies ↗

June 04, 2026

Weight Watchers joins LillyDirect for GLP-1 access as Eli Lilly signs a kidney disease research pact with Ascidian worth up to $1.9 billion.

Via Benzinga

Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success ↗

June 04, 2026

Eli Lilly knows that its GLP-1 windfall comes with an end date, so it is acting now to prepare.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.